Longitudinal trends in the prevalence and treatment of depression among adults with cardiovascular disease: An analysis of national health and nutrition examination survey 2009–2020

• DOI: 10.3389/fpsyt.2022.943165
• Publication Date: 2022-09-08T05:19:54Z
• Authors: Zhen Feng; Wai Kei Tong; Zhijia Tang
• Keywords: Depression

Objectives To assess the contemporary prevalence and decadal trends of depression antidepressant use among adults with cardiovascular disease (CVD) in United States, as well their risk factors from 2009 to 2020. Materials methods We used National Health Nutrition Examination Survey data calculate weighted use. Adults aged 20 years or older CVD were included. Depression assessed by Patient Questionnaire (PHQ-9) self-report, respectively. Results A total 3,073 eligible participants >20 The overall defined PHQ-9 score ≥10 was 15.7% (95% CI 13.8–17.5), a steady trend during 2009–March 2020 ( p = 0.777). Female gender (aOR 1.78, 95% 1.20–2.64) sleep disorder 2.62, 1.78–3.86) independent for patients, while high education level, income, longer duration, non-current smokers considered protective factors. depressed patients 38.6%, which also remained unchanged survey period 0.699). Participants normal pattern duration significantly less likely take antidepressants 0.003). Conclusion longitudinal States have been stable over past decade, despite being higher women, those disorders. Overall, fairly low. Aggressive screening tailored treatment are recommended specific vulnerable subpopulations improve clinical outcomes.